Login to Your Account

New Leadership, New Location; F-Star Gearing up for IND Filing

By Nuala Moran
Staff Writer

Wednesday, May 16, 2012

LONDON – F-Star GmbH named a new management team and is concentrating all its research and operational activities in Cambridge, UK, as it prepares to move the first product based on its novel bi-specific antibody technology into clinical development.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription